ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA

被引：41
|
作者：
ONISHI, S
SAIBARA, T
FUJIKAWA, M
SAKAEDA, H
MATSUURA, Y
MATSUNAGA, Y
YAMAMOTO, Y
机构：
来源：
HEPATOLOGY | 1989年 / 10卷 / 03期
关键词：
D O I：
10.1002/hep.1840100318
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：349 / 353
页数：5
相关论文
共 50 条
  • [21] ADOPTIVE IMMUNOTHERAPY USING LYMPHOKINE-ACTIVATED KILLER CELLS
    FOWLER, JE
    JOURNAL OF UROLOGY, 1988, 139 (01): : 148 - 149
  • [22] SUCCESSFUL IMMUNOTHERAPY OF MURINE EXPERIMENTAL HEPATIC METASTASES WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
    LAFRENIERE, R
    ROSENBERG, SA
    CANCER RESEARCH, 1985, 45 (08) : 3735 - 3741
  • [23] TREATMENT WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND INTERLEUKIN-2
    DEGOS, L
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (1-2): : 119 - 122
  • [24] LYMPHOKINE-ACTIVATED KILLER CELL PLUS RECOMBINANT INTERLEUKIN-2 THERAPY OF ERYTHROLEUKEMIA IN MICE
    JOHNSON, CS
    THURLOW, SM
    FURMANSKI, P
    LEUKEMIA, 1989, 3 (02) : 91 - 96
  • [25] SEVERE INTRAHEPATIC CHOLESTASIS IN PATIENTS TREATED WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    HOFFMAN, M
    MITTELMAN, A
    DWORKIN, B
    ROSENTHAL, W
    BENECK, D
    GAFNEY, E
    ARLIN, Z
    LEVITT, D
    PODACK, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (02) : 175 - 178
  • [26] AN ADOPTIVE IMMUNOTHERAPY OF PATIENTS WITH MEDULLOBLASTOMA BY LYMPHOKINE-ACTIVATED KILLER CELLS (LAK)
    OKAMOTO, Y
    SHIMIZU, K
    TAMURA, K
    MIYAO, Y
    YAMADA, M
    MATSUI, Y
    TSUDA, N
    TAKIMOTO, H
    HAYAKAWA, T
    MOGAMI, H
    ACTA NEUROCHIRURGICA, 1988, 94 (1-2) : 47 - 52
  • [27] ADOPTIVE IMMUNOTHERAPY FOR RECURRENT GLIOBLASTOMA-MULTIFORME USING LYMPHOKINE ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
    MERCHANT, RE
    GRANT, AJ
    MERCHANT, LH
    YOUNG, HF
    CANCER, 1988, 62 (04) : 665 - 671
  • [28] DEFECTIVE FUNCTION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND NATURAL-KILLER CELLS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    SAIBARA, T
    ONISHI, S
    SAKAEDA, H
    YAMAMOTO, Y
    HEPATOLOGY, 1989, 9 (03) : 471 - 476
  • [29] Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors
    Sankhla, SK
    Nadkarni, JS
    Bhagwati, SN
    JOURNAL OF NEURO-ONCOLOGY, 1996, 27 (02) : 133 - 140
  • [30] PULMONARY TOXICITY OF RECOMBINANT INTERLEUKIN-2 PLUS LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    VILLANI, F
    GALIMBERTI, M
    RIZZI, M
    MANZI, R
    EUROPEAN RESPIRATORY JOURNAL, 1993, 6 (06) : 828 - 833
12345